• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating.囊性纤维化跨膜传导调节因子苯丙氨酸508侧链在离子通道门控中的作用。
J Physiol. 2006 Apr 15;572(Pt 2):347-58. doi: 10.1113/jphysiol.2005.099457. Epub 2006 Feb 16.
2
CFTR gating II: Effects of nucleotide binding on the stability of open states.囊性纤维化跨膜传导调节因子门控II:核苷酸结合对开放状态稳定性的影响。
J Gen Physiol. 2005 Apr;125(4):377-94. doi: 10.1085/jgp.200409228. Epub 2005 Mar 14.
3
The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.ΔF508 囊性纤维化突变会损害结构域间的相互作用,并阻止囊性纤维化跨膜传导调节因子(CFTR)的翻译后折叠。
Nat Struct Mol Biol. 2005 Jan;12(1):17-25. doi: 10.1038/nsmb882. Epub 2004 Dec 26.
4
The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics.囊性纤维化跨膜传导调节因子(CFTR)的两个ATP结合位点在门控动力学和能量学中发挥着不同的作用。
J Gen Physiol. 2006 Oct;128(4):413-22. doi: 10.1085/jgp.200609622. Epub 2006 Sep 11.
5
On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator.关于囊性纤维化跨膜传导调节因子中R117H突变导致门控缺陷的机制
J Physiol. 2016 Jun 15;594(12):3227-44. doi: 10.1113/JP271723. Epub 2016 Mar 23.
6
Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme.三磷酸腺苷水解对囊性纤维化跨膜传导调节因子氯离子通道的门控作用。一种循环门控机制的定量分析。
J Gen Physiol. 1999 Apr;113(4):541-54. doi: 10.1085/jgp.113.4.541.
7
Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator).沃克突变揭示了纯化的囊性纤维化跨膜传导调节因子(CFTR)的催化活性与通道门控活性之间的松散关系。
Biochemistry. 1999 Feb 2;38(5):1463-8. doi: 10.1021/bi982243y.
8
Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.回复突变体G550E和4RK通过不同机制挽救囊性纤维化跨膜传导调节因子第一个核苷酸结合结构域中的突变体。
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17891-6. doi: 10.1073/pnas.0608312103. Epub 2006 Nov 10.
9
Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating.核苷酸与囊性纤维化跨膜传导调节因子(CFTR)氨基末端核苷酸结合结构域的长时间非水解相互作用及其在通道门控中的作用。
J Gen Physiol. 2003 Sep;122(3):333-48. doi: 10.1085/jgp.200308798.
10
Thermodynamics of CFTR channel gating: a spreading conformational change initiates an irreversible gating cycle.囊性纤维化跨膜传导调节因子(CFTR)通道门控的热力学:一种扩展的构象变化引发不可逆的门控循环。
J Gen Physiol. 2006 Nov;128(5):523-33. doi: 10.1085/jgp.200609558. Epub 2006 Oct 16.

引用本文的文献

1
Esc peptides and derivatives potentiate the activity of CFTR with gating defects and display antipseudomonal activity in cystic fibrosis-like lung disease.Esc肽及其衍生物可增强具有门控缺陷的囊性纤维化跨膜传导调节因子(CFTR)的活性,并在类囊性纤维化肺病中表现出抗铜绿假单胞菌活性。
Cell Mol Life Sci. 2025 Mar 18;82(1):121. doi: 10.1007/s00018-025-05633-9.
2
Nanomechanics combined with HDX reveals allosteric drug binding sites of CFTR NBD1.纳米力学与氢氘交换相结合揭示了CFTR NBD1的变构药物结合位点。
Comput Struct Biotechnol J. 2022 May 23;20:2587-2599. doi: 10.1016/j.csbj.2022.05.036. eCollection 2022.
3
The molecular evolution of function in the CFTR chloride channel.CFTR 氯离子通道功能的分子进化。
J Gen Physiol. 2021 Dec 6;153(12). doi: 10.1085/jgp.202012625. Epub 2021 Oct 14.
4
A topological switch in CFTR modulates channel activity and sensitivity to unfolding.囊性纤维化跨膜传导调节因子中的一种拓扑学转换可调节通道活性及对去折叠的敏感性。
Nat Chem Biol. 2021 Sep;17(9):989-997. doi: 10.1038/s41589-021-00844-0. Epub 2021 Aug 2.
5
VX-770-mediated potentiation of numerous human CFTR disease mutants is influenced by phosphorylation level.VX-770 增强了许多人类 CFTR 疾病突变体的功能,其效果受磷酸化水平的影响。
Sci Rep. 2019 Sep 17;9(1):13460. doi: 10.1038/s41598-019-49921-4.
6
Identifying the molecular target sites for CFTR potentiators GLPG1837 and VX-770.鉴定 CFTR 增效剂 GLPG1837 和 VX-770 的分子靶位。
J Gen Physiol. 2019 Jul 1;151(7):912-928. doi: 10.1085/jgp.201912360. Epub 2019 Jun 4.
7
Molecular dynamics simulation study on the structural instability of the most common cystic fibrosis-associated mutant ΔF508-CFTR.最常见的囊性纤维化相关突变体ΔF508-CFTR结构不稳定性的分子动力学模拟研究
Biophys Physicobiol. 2018 Feb 6;15:33-44. doi: 10.2142/biophysico.15.0_33. eCollection 2018.
8
Structural stability of purified human CFTR is systematically improved by mutations in nucleotide binding domain 1.纯化的人 CFTR 的结构稳定性通过核苷酸结合域 1 中的突变得到系统改善。
Biochim Biophys Acta Biomembr. 2018 May;1860(5):1193-1204. doi: 10.1016/j.bbamem.2018.02.006. Epub 2018 Feb 7.
9
A common mechanism for CFTR potentiators.CFTR 增效剂的共同机制。
J Gen Physiol. 2017 Dec 4;149(12):1105-1118. doi: 10.1085/jgp.201711886. Epub 2017 Oct 27.
10
Deletion of Phenylalanine 508 in the First Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Increases Conformational Exchange and Inhibits Dimerization.囊性纤维化跨膜传导调节因子第一个核苷酸结合结构域中苯丙氨酸508的缺失增加了构象交换并抑制二聚化。
J Biol Chem. 2015 Sep 18;290(38):22862-78. doi: 10.1074/jbc.M115.641134. Epub 2015 Jul 6.

本文引用的文献

1
CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains.CFTR通道通过其核苷酸结合结构域由ATP驱动的紧密二聚化而开放。
Nature. 2005 Feb 24;433(7028):876-80. doi: 10.1038/nature03313.
2
Side chain and backbone contributions of Phe508 to CFTR folding.苯丙氨酸508对囊性纤维化跨膜传导调节因子折叠的侧链和主链贡献。
Nat Struct Mol Biol. 2005 Jan;12(1):10-6. doi: 10.1038/nsmb881. Epub 2004 Dec 26.
3
The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.ΔF508 囊性纤维化突变会损害结构域间的相互作用,并阻止囊性纤维化跨膜传导调节因子(CFTR)的翻译后折叠。
Nat Struct Mol Biol. 2005 Jan;12(1):17-25. doi: 10.1038/nsmb882. Epub 2004 Dec 26.
4
Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure.人类囊性纤维化跨膜传导调节因子第一个核苷酸结合结构域中ΔF508突变对结构域折叠和结构的影响。
J Biol Chem. 2005 Jan 14;280(2):1346-53. doi: 10.1074/jbc.M410968200. Epub 2004 Nov 3.
5
The DeltaF508 mutation disrupts packing of the transmembrane segments of the cystic fibrosis transmembrane conductance regulator.ΔF508突变破坏了囊性纤维化跨膜传导调节因子跨膜片段的组装。
J Biol Chem. 2004 Sep 17;279(38):39620-7. doi: 10.1074/jbc.M407887200. Epub 2004 Jul 21.
6
The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover.囊性纤维化跨膜传导调节因子的第一个核苷酸结合结构域是稳定核苷酸相互作用的位点,而第二个是快速周转的位点。
J Biol Chem. 2002 May 3;277(18):15419-25. doi: 10.1074/jbc.M111713200. Epub 2002 Feb 22.
7
Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator.囊性纤维化跨膜传导调节因子两个核苷酸结合结构域中核苷酸的差异相互作用。
J Biol Chem. 2001 Apr 20;276(16):12918-23. doi: 10.1074/jbc.M100515200. Epub 2001 Jan 29.
8
Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels.苯丙氨酸508的缺失导致囊性纤维化跨膜传导调节因子(CFTR)氯通道的磷酸化依赖性激活减弱。
J Physiol. 2000 May 1;524 Pt 3(Pt 3):637-48. doi: 10.1111/j.1469-7793.2000.00637.x.
9
Rescue of dysfunctional deltaF508-CFTR chloride channel activity by IBMX.用异丁基甲基黄嘌呤(IBMX)挽救功能失调的ΔF508 - 囊性纤维化跨膜传导调节因子(CFTR)氯离子通道活性。
J Membr Biol. 1999 Jul 1;170(1):51-66. doi: 10.1007/s002329900537.
10
Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein.囊性纤维化是一种囊性纤维化跨膜传导调节蛋白糖蛋白加工错误的疾病。
Am J Hum Genet. 1999 Jun;64(6):1499-504. doi: 10.1086/302429.

囊性纤维化跨膜传导调节因子苯丙氨酸508侧链在离子通道门控中的作用。

The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating.

作者信息

Cui Liying, Aleksandrov Luba, Hou Yue-Xian, Gentzsch Martina, Chen Jey-Hsin, Riordan John R, Aleksandrov Andrei A

机构信息

Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, 27599, USA.

出版信息

J Physiol. 2006 Apr 15;572(Pt 2):347-58. doi: 10.1113/jphysiol.2005.099457. Epub 2006 Feb 16.

DOI:10.1113/jphysiol.2005.099457
PMID:16484308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1779664/
Abstract

Cystic fibrosis transmembrane conductance regulator (CFTR) is an ion channel employing the ABC transporter structural motif. Deletion of a single residue (Phe508) in the first nucleotide-binding domain (NBD1), which occurs in most patients with cystic fibrosis, impairs both maturation and function of the protein. However, substitution of the Phe508 with small uncharged amino acids, including cysteine, is permissive for maturation. To explore the possible role of the phenylalanine aromatic side chain in channel gating we introduced a cysteine at this position in cysless CFTR, enabling its selective chemical modification by sulfhydryl reagents. Both cysless and wild-type CFTR ion channels have identical mean open times when activated by different nucleotide ligands. Moreover, both channels could be locked in an open state by introducing an ATPase inhibiting mutation (E1371S). However, the introduction of a single cysteine (F508C) prevented the cysless E1371S channel from maintaining the permanently open state, allowing closing to occur. Chemical modification of cysless E1371S/F508C by sulfhydryl reagents was used to probe the role of the side chain in ion channel function. Specifically, benzyl-methanethiosulphonate modification of this variant restored the gating behaviour to that of cysless E1371S containing the wild-type phenylalanine at position 508. This provides the first direct evidence that a specific interaction of the Phe508 aromatic side chain plays a role in determining the residency time in the closed state. Thus, despite the fact that this aromatic side chain is not essential for CFTR folding, it is important in the ion channel function.

摘要

囊性纤维化跨膜传导调节因子(CFTR)是一种采用ABC转运蛋白结构基序的离子通道。在大多数囊性纤维化患者中,第一个核苷酸结合结构域(NBD1)中单个残基(苯丙氨酸508,Phe508)的缺失会损害该蛋白的成熟和功能。然而,用包括半胱氨酸在内的不带电荷的小氨基酸取代Phe508,对成熟是允许的。为了探究苯丙氨酸芳香侧链在通道门控中的可能作用,我们在无半胱氨酸的CFTR的这个位置引入了一个半胱氨酸,使其能够被巯基试剂选择性化学修饰。当被不同的核苷酸配体激活时,无半胱氨酸和野生型CFTR离子通道具有相同的平均开放时间。此外,通过引入ATP酶抑制突变(E1371S),两种通道都可以被锁定在开放状态。然而,引入单个半胱氨酸(F508C)阻止了无半胱氨酸的E1371S通道维持永久开放状态,从而允许关闭发生。用巯基试剂对无半胱氨酸的E1371S/F508C进行化学修饰,以探究侧链在离子通道功能中的作用。具体而言,该变体的苄基甲硫代磺酸盐修饰将门控行为恢复到在508位含有野生型苯丙氨酸的无半胱氨酸的E1371S的门控行为。这提供了第一个直接证据,即Phe508芳香侧链的特定相互作用在决定关闭状态的停留时间中起作用。因此,尽管这个芳香侧链对于CFTR折叠不是必需的,但它在离子通道功能中很重要。